Product How it works Pricing Blog FAQ About Contact
Hyloris Pharmaceuticals

Hyloris Pharmaceuticals (EBR: HYL) revenue

Hyloris Pharmaceuticals reported revenue of €7.2m for fiscal 2025, 14.8% less than in fiscal 2024 (€8.5m). Since fiscal 2020 its revenue has grown by 4,018.3%, an average growth of 110.4% a year.

Hyloris Pharmaceuticals's best year of the last 6 was fiscal 2024. The biggest drop was in fiscal 2022, −70.9%.

Revenue, in millions of euros0.220203.120210.920222.120238.520247.22025
Embed this chart

Copy this code into your website or blog. The chart updates with each new annual report.

Revenue by fiscal year

Fiscal yearRevenueChangeOperating profitOperating margin
2025€7.2m−14.8%−€6.8m−94.5%
2024€8.5m+305.3%−€7.1m−84.3%
2023€2.1m+131.9%−€16.0m−766.3%
2022€0.9m−70.9%−€11.6m−1,293.1%
2021€3.1m+1,669.1%−€10.5m−340.5%
2020€0.2m—−€7.0m−4,014.3%

The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of euros, except per-share amounts.

Hyloris Pharmaceuticals revenue compared with its sector

By revenue for its latest fiscal year, Hyloris Pharmaceuticals ranks 51st of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Hyloris Pharmaceuticals, −14.8%.

RankCompanyRevenueRevenue growth
49thMedinCell€24.3m−12.4%
50thArcticZymes TechnologiesNOK 112.6m7.9%
51stHyloris Pharmaceuticals€7.2m−14.8%
52ndOnward Medical€5.4m6,931.2%
53rdInventiva€4.5m−51.3%

Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.

Questions about the revenue of Hyloris Pharmaceuticals

How much revenue did Hyloris Pharmaceuticals make in fiscal 2025?
Hyloris Pharmaceuticals reported revenue of €7.2m for fiscal 2025, compared with €8.5m in fiscal 2024.
How much has the revenue of Hyloris Pharmaceuticals grown?
Between fiscal 2020 and fiscal 2025 it went from €0.2m to €7.2m: 4,018.3% more, an average growth of 110.4% a year.
What was the best year for revenue at Hyloris Pharmaceuticals?
Of its last 6 fiscal years, fiscal 2024, with €8.5m.
Where does Hyloris Pharmaceuticals rank in its sector by revenue?
It ranks 51st of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
Where do the figures for Hyloris Pharmaceuticals come from?
From the report Hyloris Pharmaceuticals files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.

Where each figure comes from

From the annual report Hyloris Pharmaceuticals files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2021. More on Hyloris Pharmaceuticals: the Hyloris Pharmaceuticals page · annual accounts · net income.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.